Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Neelam Thukral
Institution:
Indiana Hemophilia and Thrombosis Center
Observed institutions:
University of Michigan,
Great Ormond Street Hospital for Children NHS Foundation Trust,
Meyer Children's Hospital,
Indiana Hemophilia and Thrombosis Center,
University of California, Davis
OpenAlex ID:
A5027770353
Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials
2015
·
Alex S. Willoughby
, Gui-shuang Ying
, et al.
·
Ophthalmology
·
220
Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)
2014
·
Michael M. Altaweel
, Michael M. Altaweel
, et al.
·
Ophthalmology
·
51
Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency
2018
·
Amy D. Shapiro
, Charles Nakar
, et al.
·
Blood
·
48
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials
2022
·
Jason Q. Core
, Maxwell Pistilli
, et al.
·
Ophthalmology Retina
·
22
Treatment of Ligneous Conjunctivitis with Plasminogen Eyedrops
2022
·
Roberto Caputo
, Amy D. Shapiro
, et al.
·
Ophthalmology
·
13
Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials
2023
·
Katie Xue
, Peiying Hua
, et al.
·
Ophthalmology Retina
·
7
Safety & Efficacy of Human Plasma Derived Plasminogen Ophthalmic Drops for Treatment of Ligneous Conjunctivitis: Report of Phase 2/3 Clinical Trial
2015
·
Charles T Nakar
, Roberto Caputo
, et al.
·
Blood
·
6
Acute Airway Obstruction in 4 Pediatric Patients with Congenital Plasminogen Deficiency (C-PLGD) Treated with Intravenous Plasminogen (Human) Replacement Therapy Under an Expanded Access Protocol
2020
·
Charles Nakar
, Neelam Thukral
, et al.
·
Blood
·
5
Safety and Efficacy of Long‐Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement Therapy
2025
·
Amy D. Shapiro
, Heather McDaniel
, et al.
·
Haemophilia
·
4
Case Report: Respiratory lesions successfully treated with intravenous plasminogen, human-tvmh, replacement therapy in four patients with plasminogen deficiency type 1
2024
·
Charles Nakar
, Heather McDaniel
, et al.
·
Frontiers in Pediatrics
·
4
PDF
Plasminogen Eye Drops Are Effective in Preventing Recurrence of Pseudomembranes in Ligneous Conjunctivitis: Results from the Phase 2/3 KB046 Trial
2020
·
Roberto Caputo
, Maria Teresa Sartori
, et al.
·
Blood
·
4
Pharmacokinetics, Safety, and Efficacy of Recombinant Factor VIII Fc Fusion Protein
2017
·
Kim Schafer
, James Munn
, et al.
·
Journal of Infusion Nursing
·
3
PB3837 Allelic Expression of Factor V Leiden Mutation and Risk of Thrombosis
2026
·
Eman Abdelghani
, Kenneth Mann
, et al.
·
Research and Practice in Thrombosis and Haemostasis
PB1404 Genetic Landscape of Congenital Plasminogen Deficiency using NGS analysis
2026
·
Andrea Cairo
, Nidra Rodriguez
, et al.
·
Research and Practice in Thrombosis and Haemostasis
PB1406 Clinical and biochemical characterization of a large cohort of patients with plasminogen deficiency
2026
·
Marzia Menegatti
, Joel Bowen
, et al.
·
Research and Practice in Thrombosis and Haemostasis
Plain language summary: How safe and effective is long-term treatment with intravenous plasminogen concentrate for people with type 1 plasminogen deficiency?
2026
·
Amy D. Shapiro
, Heather McDaniel
, et al.
·
Therapeutic Advances in Hematology
Show more works
View as search
Works count:
16
Citation count:
387
H-index:
6
I10-index:
5
Year
Topic
Type
